1. Academic Validation
  2. G-quadruplexes in monkeypox virus are potential antiviral targets

G-quadruplexes in monkeypox virus are potential antiviral targets

  • J Med Virol. 2022 Nov 11. doi: 10.1002/jmv.28299.
Lu Lv 1 2 3 Leiliang Zhang 1 2 3
Affiliations

Affiliations

  • 1 Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • 2 Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • 3 Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Abstract

Monkeypox virus (MPXV) is a member of Orthopoxvirus in the Poxviridae family, causing a Public Health Emergency of International Concern (PHEIC). The numbers of cases and geographic range have increased significantly in 2022. Identification of MPXV-specific therapeutic targets is urgent. G-quadruplex (GQ) secondary structures attract great attention as potential targets for antiviral strategy. Whether GQs are present in MPXV genome remains inconclusive. In this study, we aim to characterize the GQs encoded by MPXV. Through a series of biophysical experiments, we characterized the formation potential of MPXV-encoded GQs and evaluated the binding and stabilization abilities of GQ ligands including BRACO-19, PDS, and TMPyP4 to GQs encoded by MPXV. Moreover, GQ ligands suppressed the gene transcription of MPXV sequences containing GQ. BRACO-19 and TMPyP4 were able to inhibit VACV replication. We demonstrated the existence of MPXV GQ and reinforced the idea that GQs could be novel antiviral targets. Targeting these GQ sequences with GQ binding molecules may represent a new approach for MPXV therapy. This article is protected by copyright. All rights reserved.

Keywords

BRACO-19; G-quadruplex; TMPyP4; monkeypox virus; vaccinia virus.

Figures
Products